CureVac N.V. (NASDAQ:CVAC) shares, rose in value, with the stock price down by -7.97% to the previous day’s close as strong demand from buyers drove the stock to $2.31.
Actively observing the price movement in the last trading, the stock closed the session at $2.51. Referring to stock’s 52-week performance, its high was $12.36, and the low was $2.34. On the whole, CVAC has fluctuated by -21.43% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 59.34M, with a low estimate of 20.11M and a high estimate of 77.06M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 36.12M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVAC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CVAC currently trading nearly -17.70% and -25.80% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.03, while the 7-day volatility ratio is showing 7.70% which for the 30-day chart, stands at 6.30%. Furthermore, CureVac N.V. (CVAC)’s beta value is 2.51, and its average true range (ATR) is 0.18.
A comparison of CureVac N.V. (CVAC) with its peers suggests the former has fared considerably weaker in the market. CVAC showed an intraday change of -7.97% in last session, and over the past year, it shrunk by -68.14%%.
Data on historical trading for CureVac N.V. (NASDAQ:CVAC) indicates that the trading volumes over the past 3 months, they’ve averaged 789.46K. According to company’s latest data on outstanding shares, there are 223.88 million shares outstanding.
Nearly 59.08% of CureVac N.V.’s shares belong to company insiders and institutional investors own 10.02% of the company’s shares. The stock has fallen by -45.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVAC stock heading into the next quarter.
